1. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
   Sepideh Mirzaei et al, 2021, European Journal of Pharmacology CrossRef
2. Altered translation initiation ofGja1limits gap junction formation during epithelial–mesenchymal transition
   Carissa C. James et al, 2018, Molecular Biology of the Cell CrossRef
3. Connexin 32 overexpression increases proliferation, reduces gap junctional intercellular communication, motility and epithelial-to-mesenchymal transition in Hs578T breast cancer cells
   Deniz Ugur et al, 2022, Journal of Cell Communication and Signaling CrossRef
4. GJA4 expressed on cancer associated fibroblasts (CAFs)—A ‘promoter’ of the mesenchymal phenotype
   Qian-wen Ye et al, 2024, Translational Oncology CrossRef
5. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
   Yaser E. Alqurashi et al, 2023, Environmental Research CrossRef
6. The role of connexins in breast cancer: from misregulated cell communication to aberrant intracellular signaling
   Yagmur Ceren Unal et al, 2022, Tissue Barriers CrossRef
7. Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway
   Hongyu Li et al, 2022, Oncology Reports CrossRef
8. Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma
   Wan-Ting Wang et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
9. Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications
   Stavros P. Papadakos et al, 2024, Cancers CrossRef